<DOC>
	<DOCNO>NCT03057132</DOCNO>
	<brief_summary>The objective pilot study evaluate feasibility , safety efficacy 3M™ Cavilon™ Advanced Skin Protectant use management damage skin expose caustic body fluid ostomy , drain site fistula .</brief_summary>
	<brief_title>Use 3M Cavilon Advanced Skin Protectant Management Damaged Skin Around Ostomy , Drain Fistula</brief_title>
	<detailed_description>This pilot study evaluate product , 3M™ Cavilon™ Advanced Skin Protectant , management skin around ostomy , drain and/or fistula . All subject receive product 14 day . The primary site must red skin breakdown ( i.e . skin erosion denudation denudation skin alone ) . Secondary site red skin without breakdown . Product apply twice/week frequently additional application need due leakage , skin irritation standard care . Skin assessment ( include photography ) complete baseline follow-up visit .</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Protective Agents</mesh_term>
	<criteria>1 . Is subject 18 year age old ? 2 . Does subject red skin breakdown ( i.e . skin erosion denudation denudation skin alone ) primary site ostomy , drain and/or fistula ? 3 . Is subject willing photograph take skin permit use photograph potential publication ? 4 . Is subject willing release right 3M use photo ? 5 . Is reasonable expectation subject hospital available followup visit 14 day study period ? 6 . Has subject sign Institutional Review Boardapproved inform consent/assent document authorize use disclosure protect health information ? 1 . If female , subject pregnant breast feed give birth within 3 week precede screen visit ? 2 . Does subject know allergy acrylate cyanoacrylates ? 3 . Does subject preexist skin disease area affect may make skin assessment study difficult ? 4 . Does skin area affected require treatment concomitant medication product ? 5 . Has subject receive antifungal powder area affect within 24 hour prior enrollment ? 6 . Has subject receive cyanoacrylate base skin protectant ( Marathon ) within 72 hour prior enrollment ? 7 . Does subject medical condition opinion investigator exclude him/her participate study ? 8 . Has subject enrol investigational study product apply propose study sit within 30 day screen visit ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>